Jiangsu Kanion Pharmaceutical Co Ltd

SHG:600557 China Drug Manufacturers - Specialty & Generic
Market Cap
$1.10 Billion
CN¥8.05 Billion CNY
Market Cap Rank
#9028 Global
#1799 in China
Share Price
CN¥14.22
Change (1 day)
+1.43%
52-Week Range
CN¥12.48 - CN¥19.83
All Time High
CN¥33.10
About

Jiangsu Kanion Pharmaceutical Co.,Ltd. researches and develops, produces, and sells Chinese medicines. It also offers medicines in the fields of anti-infections, orthopedics, gynecology, cardio and cerebrovascular, tonic-class, and others. In addition, the company provides herb extracts and formula granules, as well as OEM/ODM services. Jiangsu Kanion Pharmaceutical Co.,Ltd. was founded in 1975 a… Read more

Jiangsu Kanion Pharmaceutical Co Ltd (600557) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2025: 0.041x

Based on the latest financial reports, Jiangsu Kanion Pharmaceutical Co Ltd (600557) has a cash flow conversion efficiency ratio of 0.041x as of September 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥201.83 Million) by net assets (CN¥4.91 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Jiangsu Kanion Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2001–2024)

This chart illustrates how Jiangsu Kanion Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Jiangsu Kanion Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jiangsu Kanion Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Jiangsu Kanion Pharmaceutical Co Ltd (2001–2024)

The table below shows the annual cash flow conversion efficiency of Jiangsu Kanion Pharmaceutical Co Ltd from 2001 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥4.71 Billion CN¥702.49 Million 0.149x -17.38%
2023-12-31 CN¥5.38 Billion CN¥972.32 Million 0.181x -10.47%
2022-12-31 CN¥4.93 Billion CN¥995.94 Million 0.202x -0.60%
2021-12-31 CN¥4.47 Billion CN¥908.30 Million 0.203x +25.32%
2020-12-31 CN¥4.33 Billion CN¥701.10 Million 0.162x -28.45%
2019-12-31 CN¥4.09 Billion CN¥925.73 Million 0.226x +38.52%
2018-12-31 CN¥3.89 Billion CN¥636.39 Million 0.164x +53.44%
2017-12-31 CN¥3.59 Billion CN¥382.93 Million 0.107x +14.25%
2016-12-31 CN¥3.21 Billion CN¥299.02 Million 0.093x -47.99%
2015-12-31 CN¥2.87 Billion CN¥514.80 Million 0.179x +47.14%
2014-12-31 CN¥2.56 Billion CN¥311.54 Million 0.122x -39.25%
2013-12-31 CN¥1.93 Billion CN¥388.11 Million 0.201x +56.12%
2012-12-31 CN¥1.65 Billion CN¥212.11 Million 0.129x +110.14%
2011-12-31 CN¥1.47 Billion CN¥90.19 Million 0.061x -54.27%
2010-12-31 CN¥1.24 Billion CN¥166.40 Million 0.134x +759.34%
2009-12-31 CN¥1.08 Billion CN¥-21.87 Million -0.020x -133.16%
2008-12-31 CN¥954.72 Million CN¥58.39 Million 0.061x -63.20%
2007-12-31 CN¥557.95 Million CN¥92.73 Million 0.166x -24.83%
2006-12-31 CN¥492.91 Million CN¥108.98 Million 0.221x -0.20%
2005-12-31 CN¥457.89 Million CN¥101.44 Million 0.222x +323.09%
2004-12-31 CN¥414.10 Million CN¥21.68 Million 0.052x +14.61%
2003-12-31 CN¥374.88 Million CN¥17.13 Million 0.046x +36.56%
2002-12-31 CN¥333.38 Million CN¥11.15 Million 0.033x -88.24%
2001-12-31 CN¥73.91 Million CN¥21.02 Million 0.284x --